efficacy and safety of m-pola for r/r b-cell nhl
Published 3 years ago • 47 plays • Length 5:04Download video MP4
Download video MP3
Similar videos
-
2:39
ifn-beta-1a for preventing toxicities after cd19-directed car t-cell therapy: a trial in progress
-
3:14
using machine learning to identify trajectories of hematotoxicity following car t-cell therapy
-
2:41
cell avidity as a predictor of t-cell efficacy
-
5:15
the promise of immunotherapies in t-cell lymphoma
-
8:57
outcomes of sct in t-all and t-lbl
-
3:51
sickle cell disease | moa animation
-
6:23
fc bridged cell-mediated cytotoxicity
-
2:21
car t-cell therapy: how does it work?
-
2:53
autohct in dlbcl in the car-t era
-
0:59
the safety and efficacy of etavopivat in scd
-
2:41
safety and efficacy of actaly-cel™ in r/r pediatric b-all
-
3:05
car-t therapy in r/r dlbcl
-
2:43
resistance to car t-cell therapy
-
0:54
car t-cell therapy in the field of autoimmune disease
-
1:56
advances in off-the-shelf third-party t-cells for the treatment of infectious diseases post-bmt
-
1:48
do all patients require maintenance therapy following allosct?
-
2:07
the clearance of driver mutations following allosct impacts myelofibrosis disease outcomes
-
1:47
identifying positive regulators of t cell functions to improve cellular therapies
-
1:13
efficacy of transplantation in hl
-
2:08
cellular and targeted therapies for hodgkin lymphoma
-
4:04
results of phase ii trial to assess the efficacy and safety of idelalisib
-
2:17
the impact of checkpoint inhibitor-based salvage regimens in patients with r/r hl undergoing autosct